GMED vs. EW

In the year-to-date period, GMED achieves a 53.46% return, which is significantly higher than EW's -4.51% return. Both investments have delivered pretty close results over the past 10 years, with GMED having a 12.98% annualized return and EW not far behind at 12.64%.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current GMED Sharpe Ratio is 1.90, which is higher than the EW Sharpe Ratio of -0.07. The chart below compares the historical Sharpe Ratios of GMED and EW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither GMED nor EW has paid dividends to shareholders.

The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum EW drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for GMED and EW. For additional features, visit the drawdowns tool.

The current volatility for Globus Medical, Inc. (GMED) is 5.19%, while Edwards Lifesciences Corporation (EW) has a volatility of 8.07%. This indicates that GMED experiences smaller price fluctuations and is considered to be less risky than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Globus Medical, Inc. and Edwards Lifesciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.